A Retrospective Study Assessing Acute Tolerability Of The Gadolinium-Based Contrast Agents (GBCAs) In Clinical Practice.
Phase of Trial: Phase IV
Latest Information Update: 02 Mar 2017
At a glance
- Drugs Gadobenic acid (Primary) ; Gadobutrol (Primary) ; Gadopentetic acid (Primary) ; Gadoterate-meglumine (Primary) ; Gadoxetate disodium (Primary)
- Indications Biliary tract disorders; Bladder disorders; Brain disorders; Breast cancer; Colorectal cancer; Head and neck cancer; Liver disorders; Ovarian cancer; Pancreatic disorders; Rectal cancer; Renal cancer; Sarcoma; Tumours; Uterine cancer
- Focus Adverse reactions
- 02 Mar 2017 New trial record